Navigation Links
Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
Date:7/14/2009

d by low levels or absence of a protein called a clotting factor, essential for blood clotting. This inability to clot results from an error in a person's genetic code, and occurs in approximately 1 in 10,000 male births. It is estimated that over 400,000 people worldwide suffer from hemophilia, of which only 25% currently receive therapy. It is estimated that the market for hemophilia treatment is in excess of seven billion dollars annually. There are two types of hemophilia, hemophilia A and hemophilia B. Hemophilia A is caused by a lack of Factor VIII and hemophilia B is caused by a deficiency of Factor IX.

About Inspiration Biopharmaceuticals

Inspiration Biopharmaceuticals was founded in 2004 with the mission to revolutionize treatments for hemophilia. The Company is focused on developing products that have the potential to broaden patient access to therapy, including prophylactic use. Greater access and more frequent prophylactic therapy have been shown to reduce complications of the disease and enhance patients' long-term health and quality of life.

Underlying the Company's programs is a novel, proprietary manufacturing technology that allows a greater yield of high-quality protein. Inspiration is utilizing this technology to develop a portfolio of hemophilia and bleeding disorder products that address a $7 billion market worldwide. Inspiration's lead product candidate IB1001, an intravenous recombinant Factor IX, has completed preclinical testing and is now being evaluated in a Phase 1/2-3 clinical study in the United States and Israel and is poised to enter clinical testing in Europe.


'/>"/>
SOURCE Inspiration Biopharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
2. Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
3. Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
4. Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
6. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
7. Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
8. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
9. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2008 Financial Results on Friday, March 13, 2009 at 8:30am EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Ill. (PRWEB) May 16, 2013 ... and portable models, from Cole-Parmer is designed to ... enhanced line includes: , The new Cole-Parmer® ... true workhorses in the lab. They ensure a ... and plasma specimen separation. Their standard four-place swinging ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... software solutions, today announces new Phase II SBIR ... the continued development of an open-source, high performance ... model-centric integration framework enables researchers to select only ... set of simulation, computation, or analysis tasks. ...
(Date:5/16/2013)... SAN DIEGO , May 16, 2013  The ... the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, ... will be held May 28-31 at the Hilton San ... finishing touches on this year,s conference and want to ... opportunity to attend," said Brandi Roberts ...
(Date:5/16/2013)... As the weather warms, women everywhere are ... looks. While most make a statement with fashion, many change ... the warmer weather mixes makeup and sweat to produce, and ... of acne during warmer months, Adult Acne treatment , ... the best ways to deter breakouts. , Recently, an ...
Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2
... Author: , ... Analytical Sciences , 710 Bridgeport Avenue ... Introduction , ... added to gasoline to produce fuel with increased oxygen content. Oxygenated fuel is desirable ...
... Thomas Wampler , CDS Analytical, Inc. ... Oxford, PA 19363-0277 , ... analytical pyrolysis 1 with gas chromatography/ mass spectrometry (GC/MS) to study the structure of ... elevated temperatures. The utility of the technique is based on the application of thermal energy ...
... In biological research laboratories, filtration techniques are ... solvents and buffers, and separate and purify samples for processing. ... vacuum is applied. , The ... more than 120 to 50 Torr (25 28Hg). A ...
Cached Biology Technology:Analysis of Fuel Oxygenates by U.S. EPA Method 8260B Using Headspace Trap with GC/MS 2Analysis of Fuel Oxygenates by U.S. EPA Method 8260B Using Headspace Trap with GC/MS 3Analysis of Fuel Oxygenates by U.S. EPA Method 8260B Using Headspace Trap with GC/MS 4Polymer Degradation Mechanisms Encountered in Pyrolysis-GC/MS 2Polymer Degradation Mechanisms Encountered in Pyrolysis-GC/MS 3Polymer Degradation Mechanisms Encountered in Pyrolysis-GC/MS 4 Improving the Efficiency of Common Filtration Tasks in your Laboratory 2 Improving the Efficiency of Common Filtration Tasks in your Laboratory 3
(Date:5/16/2013)... 16, 2013 The relationship between the heritable ... not been clear. Schizophrenia is commonly associated with ... are clues that reduced IQ may be linked ... reduced cognitive ability may precede the onset of ... in healthy relatives of people diagnosed with schizophrenia. ...
(Date:5/16/2013)... bone marrow in the liver, the spleen or ... that a specific type of immune cell facilitates such ... is essential for the function of the immune system. ... liver and the spleen. Later the process is delegated ... as the sole source of blood cells for the ...
(Date:5/16/2013)... NEW YORK , May 16, 2013 ... market research report is available in its ... Market Forecast & Opportunities, 2018 ... data protection and old security practises such ... driven the growth of biometric technologies in ...
Breaking Biology News(10 mins):Genetic risk for schizophrenia is connected to reduced IQ 2Herpes infections: Natural killer cells activate hematopoiesis 2Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7
... Although the two disorders may seem dissimilar, epilepsy ... likely to have schizophrenia, and a family history of ... not known whether the converse is true, i.e., whether ... for epilepsy. Multiple studies using varied investigative ...
... to be reformed if it is to meaningfully affect ... articles by Stanford writers. The debate over how ... amid taxpayers, $500 million tab for the bankruptcy of ... government budget cuts and plunging U.S. prices for natural ...
... EAST LANSING, Mich. Michigan State University researchers, with ... a clinical trial in Africa they hope will provide ... survive cerebral malaria but are left stricken with epilepsy ... disorders via loss of human potential and lack of ...
Cached Biology News:Evidence of familial vulnerability for epilepsy and psychosis 2America's clean energy policies need a reality check, say Stanford researchers 2America's clean energy policies need a reality check, say Stanford researchers 3America's clean energy policies need a reality check, say Stanford researchers 4Drug could reverse scourge of cerebral malaria for survivors 2Drug could reverse scourge of cerebral malaria for survivors 3
These 22x40mm rectangular No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick. • Approx. Pcs Oz : 73...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
... Top cover cold rolled steel with stove ... surface polyethylene Front, ... 3 UV lamps Internal ... interlocked with fluorescent light Lighting ...
... Shaker provides the exact agitation needed ... very slow to fast speed and ... a gentle wave motion that lifts ... membranes to achieve faster, more uniform ...
Biology Products: